Condition
Allergic Airway Disease
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
4 treatments under study, led by Corticosteroids
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
Phase 4 (1)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT00779636Phase 4CompletedPrimary
Effectiveness and Safety of Desloratadine in Patients With Allergic Airway Disease During the Pollen Season (Study P03284)
NCT00882115Not ApplicableCompletedPrimary
Broccoli Sprout Extract Effects on Allergic Inflammation in the Nose
NCT00032526Not ApplicableUnknownPrimary
Classical Conditioning to Treat Allergic Airway Diseases
Showing all 3 trials
Research Network
Common Treatments
- Corticosteroids1
- Broccoli Sprout Extract Bse1
- Classical Conditioning To Corticosteroid1
- Desloratadine1
Active Sponsors
- National Center for Research Resources (NCRR)1
- Organon and Co1
- University of California, Los Angeles1
Top Investigators
University of California, Los Angeles